You searched for "macular"
Migraine attack: does retinal and peripapillary blood flow change?
7 April 2021
| Claire Howard
|
EYE - Neuro-ophthalmology
This prospective clinical study compared retinal and peripapillary blood flow parameters in migraine patients during an attack with healthy controls using optical coherence tomography angiography (OCTA). OCTAs were performed on 52 eyes from 26 migraine sufferers and 48 eyes from...
Internal limiting membrane (ILM) peeling on blood flow in diabetic macula
2 February 2024
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
|
Diabetes, Epiretinal membrane, Inner limiting membrane, vessel density, vessel length density
This is a retrospective review of notes for diabetic patients with epiretinal membrane (ERM) who underwent surgery by the same surgeon. Nineteen had ERM peeling only, while the remaining 18 had both ERM and internal limiting membrane (ILM) peeling. The...
Causes of abnormal head postures – literature review
Yadegari reports a narrative literature review for abnormal head postures (AHPs) with discussion on different causes. This review summarises the control of a normal head posture before discussing differences of ocular vs non-ocular AHPs. Ocular AHPs may be adopted to...Hot debates in medical retina and imaging: Perspectives from the Controversies in Ophthalmology 2020 virtual conference
Controversies in medical retina and imaging were debated during the Controversies in Ophthalmology 2020 virtual conference held during two mid-day scientific sessions on 27 and 28 March 2020. The author recounts key perspectives and presents viewpoint recommendations from the Vision...
Clinical features of ocular syphilis
7 December 2020
| Su Young
|
EYE - Vitreo-Retinal
The study looked at 24 patients (20 males, four females) with serological evidence of syphilitic infection who presented to a tertiary ophthalmic centre. Ocular involvement was the first manifestation of syphilitic disease in 96% and Human Immunodeficiency Virus (HIV) seropositivity...
Current concepts of the uveitis-glaucoma-hyphaema (UGH) syndrome
The authors discuss pathophysiology, aetiology and current management strategies of UGH syndrome. The clinical features of UGH are different than initial descriptions. UGH today is most often associated with posterior chamber IOLs that are not placed within the capsular bag...
Neurofibromatosis type 1 features
The aim in this study was to identify the incidence and de nova mutation rate of Neurofibramatosis type 1 (NF1) and describe the ocular and non-ocular findings in a population-based cohort of patients diagnosed over a 30-year period. The study...Manchester medical retina team to host free macula course
20 August 2021
The Manchester Macula Course will be held virtually on Wednesday 15 September and Wednesday 29 September.
Three years of experience with quantiferon-TB Gold Testing in patients with uveitis
1 April 2015
| Nikolaos D Georgakarakos
|
EYE - Vitreo-Retinal
Quantiferon-TB Gold is a new alternative to the tuberculin skin test that utilises synthetic peptides representing M. tuberculosis antigens ESAT-6, CFP-10, TB7.7 and upon incubation with whole blood IFN-γ is released from pre-sensitised T cells and can be measured by...
Quantum technology first in eye disease detection
8 January 2024
|
quantum, AMD, disease prevention, Age-related macular degeneration, CEVR, innovation
Scientists are working on a new device that could lead to a reduction in the number of people who go blind from age-related macular degeneration (AMD).
The National Treatment Centre-Highland
8 September 2023
|
National Treatment Centre-Highland, Andy Pyott, Scotland, Eyecare, Raigmore, NHS Highland
The National Treatment Centre-Highland opened its doors to patients in April 2023. At a cost of £48 million this represented a significant investment by the Scottish Government for the provision of modern eye care for the North of Scotland.
A case of ‘60-day glaucoma’
3 April 2023
| Jagruti Godhaniya, Rajan Paul
|
EYE - General
Neovascular glaucoma (NVG) has been called ‘90-’ or ‘100-day glaucoma’ in the past due to its typical development three months after the onset of central retinal vein occlusion (CRVO). In reality, NVG can occur anywhere between two weeks and two...
